Your browser doesn't support javascript.
loading
Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer.
Braig, Friederike; März, Manuela; Schieferdecker, Aneta; Schulte, Alexander; Voigt, Mareike; Stein, Alexander; Grob, Tobias; Alawi, Malik; Indenbirken, Daniela; Kriegs, Malte; Engel, Erik; Vanhoefer, Udo; Grundhoff, Adam; Loges, Sonja; Riecken, Kristoffer; Fehse, Boris; Bokemeyer, Carsten; Binder, Mascha.
Afiliación
  • Braig F; Department of Oncology and Hematology, BMT with section Pneumology, Hubertus Wald Tumorzentrum / UCCH, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • März M; Department of Oncology and Hematology, BMT with section Pneumology, Hubertus Wald Tumorzentrum / UCCH, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Schieferdecker A; Department of Oncology and Hematology, BMT with section Pneumology, Hubertus Wald Tumorzentrum / UCCH, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Schulte A; Department of Neurosurgery, Laboratory for Brain Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Voigt M; Department of Oncology and Hematology, BMT with section Pneumology, Hubertus Wald Tumorzentrum / UCCH, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Stein A; Department of Oncology and Hematology, BMT with section Pneumology, Hubertus Wald Tumorzentrum / UCCH, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Grob T; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Alawi M; Bioinformatics Service Facility, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Indenbirken D; Heinrich-Pette-Institute, Leibniz-Institute for Experimental Virology (HPI), Hamburg, Germany.
  • Kriegs M; Radiation Biology and Radio-Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Engel E; Hämatologisch-onkologische Praxis Altona (HOPA), Hamburg, Germany.
  • Vanhoefer U; Marienkrankenhaus, Zentrum für Innere Medizin, Hamburg, Germany.
  • Grundhoff A; Heinrich-Pette-Institute, Leibniz-Institute for Experimental Virology (HPI), Hamburg, Germany.
  • Loges S; Department of Oncology and Hematology, BMT with section Pneumology, Hubertus Wald Tumorzentrum / UCCH, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Riecken K; Institute for Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Fehse B; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Bokemeyer C; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Binder M; Department of Oncology and Hematology, BMT with section Pneumology, Hubertus Wald Tumorzentrum / UCCH, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Oncotarget ; 6(14): 12035-47, 2015 May 20.
Article en En | MEDLINE | ID: mdl-26059438
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores ErbB / Cetuximab / Neoplasias Gastrointestinales / Anticuerpos Monoclonales / Antineoplásicos Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Año: 2015 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores ErbB / Cetuximab / Neoplasias Gastrointestinales / Anticuerpos Monoclonales / Antineoplásicos Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Año: 2015 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos